Cold medicine

Latin America, Middle East and Africa (LAMEA) Cough Syrup Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 24, 2021
Health, Pharmaceutical, Antitussives, Cold medicine, Psychoactive drugs, Cough, Branches of biology, Clinical medicine, Lean, Suppression

Antitussives, which are also called cough suppressants, are majorly utilized to cure the symptoms of cough.

Key Points: 
  • Antitussives, which are also called cough suppressants, are majorly utilized to cure the symptoms of cough.
  • This cough suppressant helps in curing cough by decreasing the action of the cough reflex and decrease the urge to cough.
  • There are many people who use cough syrup to cure different types of cough.
  • The Cough Suppressants market dominated the Saudi Arabia Cough Syrup Market by Product in 2019, growing at a CAGR of 5.3 % during the forecast period.

North America Cough Syrup Market Report 2021: Increasing Cases of Respiratory Issues are Providing Lucrative Opportunities - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 20, 2021
Health, Pharmaceutical, Antitussives, Psychoactive drugs, Opioids, Drug culture, Hypnotics, Lean, Cold medicine, Cough, Drugs, Air pollution, Economic growth, Clinical medicine

b'The "North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.

Key Points: 
  • b'The "North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.
  • Moreover, the rising population of old age people along with increasing air pollution are driving the growth of the market.
  • However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth.
  • Moreover, the increasing disposable income of people in emerging nations will also contribute to the rising growth of the global cough syrups market.

Europe Cough Syrup Market Analysis and Forecast, 2020-2021 & Forecast to 2026 with Germany Dominating - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 20, 2021
Medical Supplies, Health, Antitussives, Psychoactive drugs, Opioids, Drug culture, Hypnotics, Lean, Articles, Cold medicine, Drugs, Distribution

b'The "Europe Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe Germany market dominated the Europe Pediatric Market by Country in 2019, growing at a CAGR of 5.7 % during the forecast period.

Key Points: 
  • b'The "Europe Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe Germany market dominated the Europe Pediatric Market by Country in 2019, growing at a CAGR of 5.7 % during the forecast period.
  • In addition, the ever-growing enhancements in products are projected to provide new growth prospects for the cough syrup market.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.
  • However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth.
  • On the other hand, the high market potential of the developing regions will garner more growth opportunities for the cough syrup market growth.\nThe Retail Pharmacy market dominated the Spain Cough Syrup Market by Distribution Channel in 2019, thereby, achieving a market value of $85.9 million by 2026.

SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI and Adds Respiratory Advisory Team

Retrieved on: 
Tuesday, May 11, 2021
Anatomy, Branches of biology, Peripheral nervous system, Cranial nerves, Gustatory system, Abdomen, Autonomic nervous system, Vagus nerve, Cough, Chronic cough, Lung, Cold medicine

"Chronic cough is a prevalent respiratory disorder that is often unexplained or refractory, and severely impacts quality of life.

Key Points: 
  • "Chronic cough is a prevalent respiratory disorder that is often unexplained or refractory, and severely impacts quality of life.
  • We aim to develop a safe and effective local-acting inhaled antitussive to address the hypersensitivity of vagal afferents that is thought to drive chronic cough.
  • Cough is mediated by sensory nerve fibers of the vagus nerve that terminate in the upper airways and lungs.
  • Dr. Ford also holds senior advisory roles with PharmNovo and for New Leaf Venture Partners, where he had previously held the title of venture partner.

NAD Finds Certain Zarbee's Claims Clearly Identify Honey as The Source of the Cough Soothing Benefit in its Cough Products; Recommends Modification of Others

Retrieved on: 
Friday, April 16, 2021
Food and drink, Demulcents, Cough, Psychoactive drugs, Cold medicine, Honey, Lean, Drugs, Halls

The honey in Zarbee\'s products is the ingredient that provides the cough soothing benefit.

Key Points: 
  • The honey in Zarbee\'s products is the ingredient that provides the cough soothing benefit.
  • "\nThe claim "[a] safe and delicious way to soothe your cough from hoarseness, dry throats, and irritants," on the website tile for "99% Honey Cough Soothers.
  • "\nThe claim on Walmart\'s website, "Zarbee\'s Naturals 99% Honey Cough Soothers calm and soothe sore throats and coughs associated with hoarseness, dry throat, and irritants.
  • "\nThe claim "Soothes coughs associated with hoarseness, dry throat, and irritants," on the labels of "Cough Syrup Dark Honey" and "Children\'s Cough Syrup Dark Honey.

National Survey Shows Slight Increase in Teen Abuse of OTC Cough Medicine

Retrieved on: 
Tuesday, December 15, 2020
Health, Consumer, Teens, Women, Other Health, MEN, Drugs, Psychoactive drugs, Neurochemistry, Dissociative drugs, NMDA receptor antagonists, Nicotinic antagonists, Antitussives, Over-the-counter drug, Pharmaceuticals policy, CHPA, Consumer Healthcare Products Association, Cold medicine

The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigans Monitoring the Future survey shows 3.7 percent of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8 percent in 2019.

Key Points: 
  • The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigans Monitoring the Future survey shows 3.7 percent of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8 percent in 2019.
  • This years survey results underscore the importance of industrys commitment to preventing teen OTC cough medicine abuse, said Scott Melville, President and CEO, Consumer Healthcare Products Association (CHPA).
  • For years, CHPA has worked to help reduce teen DXM abuse by employing three strategies: increasing parent education and engagement in abuse awareness and prevention; heightening teen perceptions of the risks and social disapproval of medicine abuse; and, limiting teen access to DXM through age-18 sales restrictions in states.
  • In 2008, CHPA member companies took a major step in preventing abuse by voluntarily placing an icon on the packaging of OTC DXM products, encouraging parents to learn more about teen medicine abuse by visiting StopMedicineAbuse.org .

Washington Poison Center warns parents of continued dangers with the Benadryl™ Challenge

Retrieved on: 
Monday, November 23, 2020
Psychoactive drugs, Drugs, Receptor antagonists, Antiemetics, Hypnotics, Muscarinic antagonists, Sedatives, Antihistamines, Diphenhydramine, Benadryl, Cold medicine, Antihistamine

Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.

Key Points: 
  • Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.
  • It is typically stored in an unsecured or unlocked cabinet, and bulk quantities are available for purchase.
  • WA Poison Center Cases of intentional self-harm or suicidal intent in adolescents ages 13-17 has increased 5% since 2019, and cases of abuse have increased 34%.
  • For questions or emergencies involving diphenhydramine or other potentially harmful substances, call the Washington Poison Center (1-800-222-1222).

Nature's Way Sambucus® Announces New Line Of Products

Retrieved on: 
Tuesday, November 3, 2020
Psychoactive drugs, Gummy candy, Lean, Cold medicine, Drugs, Clinical medicine

Nature's Way Sambucus products are rooted in the ideal that immune support can come from the best quality ingredients nature has to offer.

Key Points: 
  • Nature's Way Sambucus products are rooted in the ideal that immune support can come from the best quality ingredients nature has to offer.
  • The new Nature's Way Sambucus Sleep + Immune Gummies enable the body to get the rest it needs to perform its very best.
  • *
    The new Nature's Way Sambucus HoneyBerry is the perfect cough syrup for when you need it.
  • For more information about Nature's Way Sambucus Sleep + Immune Gummies,Nature's WaySambucus HoneyBerry Cough Syrup or other Nature's Way supplements, please visit NaturesWay.com/Brands/Sambucus or check out @NaturesWayBrands on Facebook and Instagram.

Robitussin Launches Their First-Ever Drug-Free Products for Cough Relief with a Cheerful Collaboration

Retrieved on: 
Wednesday, October 28, 2020
Antitussives, Psychoactive drugs, Cold medicine, Lean, Cough, Honey, Drugs, American culture

WARREN, N.J., Oct.28, 2020 /PRNewswire/ --GSK Consumer Healthcare (LSE/NYSE:GSK) today announced the launch of Robitussin Naturals, the brand's first-ever line of drug-free products that provide relief from occasional cough*.

Key Points: 
  • WARREN, N.J., Oct.28, 2020 /PRNewswire/ --GSK Consumer Healthcare (LSE/NYSE:GSK) today announced the launch of Robitussin Naturals, the brand's first-ever line of drug-free products that provide relief from occasional cough*.
  • Robitussin Naturals Cough Relief Syrup and Robitussin Naturals Cough Relief + Immune Health Syrup are the experts' in coughs first-of-their-kind, drug-free dietary supplements formulated with real True Source certified honey and English ivy to help relieve occasional coughs associated with hoarseness, dry throat or irritants*.
  • Robitussin Naturals Cough Relief Syrups and Gummies are available now at drugstores nationwide in varieties for both adults and children.
  • Robitussin is the #1 cough relief brand with more than 70 years of history providing consumers with powerful cough relief.

Cough & Cold Preparations Market Insights, 2015-2030 - IoMT Allowing New Business Models to Emerge and Enhancing Customer Experiences

Retrieved on: 
Thursday, March 5, 2020
Infectious diseases, Medical specialties, Health, Pharmaceuticals policy, Pharmaceutical industry, Influenza, RTT, Common cold, Counterfeit medications, Cold medicine

The cold and flu season is the major driver of sales for products related to prevention and treatment of cold and cough.

Key Points: 
  • The cold and flu season is the major driver of sales for products related to prevention and treatment of cold and cough.
  • Threat from substitute products such as generic and counterfeit drugs, is significantly restraining the global cold and cough preparations market.
  • The IoMT is allowing new business models to emerge and enhancing customer experiences.
  • Global Cold and Cough Preparations Market, Segmentation by Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion